Solvet
Solvet is a Canadian family-owned veterinary pharmaceutical manufacturer (founded 2009, Calgary) producing and distributing branded animal health products — antibiotics, vaccines, parasiticides, pain management, and biosecurity — for livestock producers, veterinarians, and pet owners across Canada.
- Company typePrivate
- Founded2009
- HeadquartersCalgary, Canada
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Solvet does
Solvet is a Canadian family-owned veterinary pharmaceutical manufacturer founded in 2009 by Dr. Merle Olson and Dr. Barbara Olson, operating as a subsidiary of Alberta Veterinary Laboratories Ltd. and headquartered in Calgary, Alberta. The company develops, manufactures, and distributes a broad animal health product portfolio spanning livestock (cattle, swine), companion animals, and equine, including antibiotics (Alamycin LA, Fenisolve, Solvatrim), anti-inflammatories and pain management (ASA Bolus, Meloxicam, Rifen, Firokare), parasiticides (Solmectin, Ivermectin), vaccines (STIMULATOR 2/5, PRO-BAC 4, Vaxxon SRP), reproductive and nutritional products, biosecurity cleaners and disinfectants, rodenticides, and differentiated proprietary brands such as CattleZen (dual-pheromone stress management) and Yummy Combs (VOHC-accepted pet dental chews). The portfolio also includes sole Canadian distribution rights for Norbrook's production-animal pharmaceutical line.
Manufacturing is conducted at a single GMP-certified, FDA-approved facility in Calgary — Solvet is the only FDA-approved animal health manufacturer in Western Canada. Revenue is generated through one-time sales of branded and distributed products, routed through veterinary distribution centers (CDMV, WDDC, VP, AVP), supported by territory field sales representatives, and amplified by continuing-education programs (ICARE Academy), industry trade shows, and government trade missions. Customers are primarily Canadian veterinarians, livestock producers, pet owners, and equine owners; the company is beginning international expansion into the US, Australia, and Ireland.
Solvet holds 50+ proprietary patents, has invested $12M+ in R&D over 15 years, employed 85 people as of its 2024 anniversary, and in April 2025 took its first external equity investment from Bonnefield Financial to scale manufacturing, distribution, compounding pharmacy, and product development.
Solvet firmographics
Firmographics- Name
- Solvet
- Legal name
- Solvet
- Website
- https://solvet.ca
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Solvet is a Canadian family-owned veterinary pharmaceutical manufacturer (founded 2009, Calgary) producing and distributing branded animal health products — antibiotics, vaccines, parasiticides, pain management, and biosecurity — for livestock producers, veterinarians, and pet owners across Canada.
- Ownership category
- akta.pro rank
Solvet industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industry
- Antimicrobials & Anti-infectives (HLAMAEAE)
Keywords
Where Solvet is headquartered
LocationHeadquarters
- HQ city
- Calgary
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Solvet business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Pharmaceutical Products: Sale of proprietary and distributed animal health pharmaceutical products including antibiotics, anti-inflammatories, parasiticides, vaccines, supplements, and pain management solutions for livestock, companion animals, and equine.
- Proprietary Branded Products: Sale of proprietary products including CattleZen, Yummy Combs, ASA Bolus, Ivermectin Liquid for Horses, Transition Calcium Bolus, and other branded veterinary health products.
- Distribution/Sole Distributor Rights: As sole Canadian distributor for Norbrook product line, Solvet earns revenue from distributing Norbrook's production animal pharmaceuticals including Alamycin, Fenisolve, Solvezine, Solvatrim, and Occluseal.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Solvet product offering
Product offeringCore offering
Solvet develops, manufactures, and distributes a comprehensive portfolio of veterinary pharmaceutical and health products for livestock, companion animals, and equine care. Its offerings include antibiotics, anti-inflammatories, parasiticides, vaccines, pain management solutions, dental chews, cattle stress management products, biosecurity cleaners, disinfectants, and rodenticides. The company operates GMP-certified, FDA-approved manufacturing facilities in Calgary, Alberta, and distributes through veterinary distribution channels across Canada and select international markets.
Product overview
Solvet is a Canadian family-owned veterinary pharmaceutical company that develops and manufactures a comprehensive portfolio of animal health products for livestock, companion animals, and equine care. The product lineup includes CattleZen (cattle stress management with pheromone technology), Yummy Combs (pet dental chews), ivermectin-based parasiticide products (Solmectin Pour-On and Injectable), antibiotics (Alamycin LA, Fenisolve, Solvatrim, Solvezine), anti-inflammatories (ASA Bolus, Meloxicam products, Rifen, Solnixon), vaccines (STIMULATOR 2/5, PRO-BAC 4, Myco-Bac, Vaxxon SRP Klebsiella/Salmonella), pain management solutions, digestive/gastrointestinal products (Charcoal-Kaolin, Kaolin-Pectin, Rumen Rx), reproductive/breeding products (GONAbreed, estroPLAN, Pluset), nutritional supplements (Transition Calcium Bolus, Cal-Boost, K-Phos-Boost, Vitaferst-Care, Bovi-MV), teat sealants (Occluseal, Solveseal BLÜ), disinfectants and cleaners (Hyperox, Biosolve Plus/AFC, Virkon products, Biosentry 904), rodenticides (Boothill, DoubleTap, Fast Draw, Hombre, Mhouse, Revolver, Aegis stations), and distributed Norbrook products. The company operates GMP manufacturing facilities in Calgary, Alberta and serves the Canadian market with select international distribution.
Differentiator
Problem solved
Functional benefit
Brands
- CattleZen: Cattle stress management tool - a proprietary blend of maternal bovine-appeasing substance and calming pheromone for beef and dairy cattle.
- Yummy Combs
Products and services
- CattleZen
- Yummy Combs®
- Ivermectin Liquid for Horses
- Alamycin 200 LA
- Alamycin 300 LA
- ASA Bolus
- Transition Calcium Bolus for Dairy Cows
- Biosolve AFC®
- Biosolve Plus®
- Hyperox®
- Virkon® Tablets
- Virkon® Greenhouse
- Solmectin Pour-On for Cattle
- Solmectin™ Injectable for Cattle and Pigs
- Solofer
- CALCI-MAG-PHOS-DEXTROSE Injection
- Solveseal BLÜ
- Occluseal / OccluSEAL
- GONAbreed
- estroPLAN
- Pluset
- STIMULATOR® 5
- STIMULATOR® 2
- Myco-Bac® with Reveal ATS™
- PRO-BAC™ 4
- Vaxxon® SRP® Klebsiella
- Vaxxon® SRP® Salmonella
- Vitaferst-Care
- Lidoband™
- Norbrook Distributed Products (Fenisolve, Solvatrim, Alamycin, Solvezine, Occluseal)
- Cal-Boost Calcium Bolus
- K-Phos-Boost Bolus
- MeloxiKare™
- Firokare™ Chewable Tablets
- PancreaKare™
- EqStim®
- Charcoal-Kaolin Oral Paste
- Rifen®
- Boothill Rodenticide
- DoubleTap™ Soft Bait Rodenticide
- Fast Draw® Soft Bait Rodenticide
- Hombre Rodenticide Mini-Block
- Mhouse™ Blocks with Bait Station
- Revolver® Soft Bait Rodenticide
- Aegis® Mouse Bait Station + key
- Aegis® RP Bait Station + key
- Biosentry® 904 Disinfectant
- NEOGEN® Viroxide Super™ Disinfectant
- Meloxicam Oral Suspension, USP
- Bovi-MV Nutritional Supplement
- Rumen Rx Powder 454g
Quantifiable outcome
- Yummy Combs reduces tartar by 25% and bad breath by 46% in 60-day clinical study
- +1 more outcomes
Companies that use Solvet
Customer profileSegments5 records
Ideal customer profiles5 records
Solvet technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Solvet partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- McCarthy Veterinary SuppliescoreStrategic partnership for Solvet's companion animal division. McCarthy Vet is a family-owned company from Airdrie, Alberta, serving Canadian veterinarians for over 60 years. Partnership combines Solvet's product development with McCarthy Vet's countrywide distribution presence.
- Norbrook Animal HealthcoreSolvet is the sole Canadian distributor of the Norbrook product line. Norbrook is one of the world's largest privately owned production animal pharmaceutical companies with $465M+ CAD annual sales across 100+ countries. Products include Alamycin, Fenisolve, Solvezine, Solvatrim, and Occluseal.
- Government of Canada (Trade Mission)minorSolvet participated in the Canadian trade mission to Australia led by Minister Mary Ng. Participated in B2B meetings with industry leaders in Brisbane and Melbourne to explore collaboration opportunities.
Scale indicators7 records
Recent moves10 records
Expansion highlights6 records
Solvet competitors and assessment
Company assessmentDirect peers
- Dechra Pharmaceuticals: Dechra is a UK-headquartered veterinary pharmaceutical company specializing in companion animal and livestock therapeutics, with a comparable product portfolio spanning anti-infectives, parasiticides, pain management, and specialty therapeutics. Recently acquired by EQT, Dechra is a globally scaled analog of Solvet's prescription veterinary pharma model.
- Virbac: Virbac is a France-based global veterinary pharmaceutical company offering a broad portfolio of products for livestock and companion animals, including antibiotics, parasiticides, vaccines, and dental care. Its animal-only focus and product breadth closely parallel Solvet's strategy, with a stronger international footprint.
- Vetoquinol: Vetoquinol is a France-based independent veterinary pharmaceutical company with a comparable focus on livestock and companion animal therapeutics, including anti-infectives, pain management, parasiticides, and reproductive health. As a family-influenced, mid-sized independent player it is highly comparable to Solvet's positioning.
- Norbrook Animal Health: Norbrook is one of the world's largest privately owned production animal pharmaceutical companies ($465M+ CAD annual sales, 100+ countries) and is now Solvet's exclusive Canadian distribution partner. Norbrook is the closest direct peer in livestock-only veterinary pharmaceuticals, with manufacturing scale and product portfolio well beyond Solvet's.
- Phibro Animal Health: Phibro Animal Health is a US-listed animal health and nutrition company focused on livestock pharmaceuticals, vaccines, and feed additives. Its livestock-heavy product portfolio (antibiotics, parasiticides, vaccines, nutritional specialties) and mid-sized independent positioning are highly comparable to Solvet.
Broad incumbents
- Zoetis: Zoetis is the world's largest animal health company, offering a comprehensive portfolio across livestock, companion animals, and equine. As the dominant global incumbent with broad species coverage, it competes with Solvet across most product categories but at vastly greater scale and commercial reach.
- Elanco Animal Health: Elanco is a global animal health leader offering pharmaceuticals, vaccines, and parasiticides across livestock and companion animals. Its broad incumbent footprint in cattle pharmaceuticals (including vaccines and anti-infectives) overlaps directly with Solvet's livestock portfolio.
- Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health division is a top global animal pharma player with strong positions in livestock vaccines, parasiticides, and companion animal therapeutics. Its broad portfolio and global commercial reach represent the kind of incumbent competition Solvet faces as it expands beyond Canada.
Emerging players
- Ceva Santé Animale: Ceva is a France-based independent global veterinary pharmaceutical company focused on livestock, companion animal, and poultry health. As a privately held, fast-growing independent, Ceva represents a comparable growth-stage competitor pursuing similar species diversification and global expansion.
- Modern Veterinary Therapeutics: Modern Veterinary Therapeutics is a privately held veterinary pharmaceutical company developing and commercializing novel therapeutics for companion animals. Its emerging-player profile and focus on differentiated proprietary products (similar to Solvet's CattleZen and Yummy Combs) make it a comparable smaller-scale peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
Solvet social profiles
Digital presenceSolvet compliance and trust
Trust signalCompliance1 record
Solvet financial estimates
Financial estimateRevenue estimate
Valuation estimate
Solvet leadership team
Management profileNumber of profiles
Profiles5 records
Solvet funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Solvet M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Solvet
What does Solvet do?
Solvet develops, manufactures, and distributes a comprehensive portfolio of veterinary pharmaceutical and health products for livestock, companion animals, and equine care. Its offerings include antibiotics, anti-inflammatories, parasiticides, vaccines, pain management solutions, dental chews, cattle stress management products, biosecurity cleaners, disinfectants, and rodenticides. The company operates GMP-certified, FDA-approved manufacturing facilities in Calgary, Alberta, and distributes through veterinary distribution channels across Canada and select international markets.
Is Solvet a public or private company?
Solvet is a private company. It is classified as family owned and is currently operating.
When was Solvet founded?
Solvet was founded in 2009. It employs 51 to 100 people.
Where is Solvet based?
Solvet is headquartered in Calgary, Canada, in the North America region.
How does Solvet make money?
Three revenue lines are on record. Veterinary Pharmaceutical Products are the primary driver. The others are proprietary Branded Products and distribution/Sole Distributor Rights.
Who are Solvet's main competitors?
Direct peers on record are Dechra Pharmaceuticals, Virbac, Vetoquinol, Norbrook Animal Health and Phibro Animal Health. Broad incumbents are Zoetis, Elanco Animal Health and Boehringer Ingelheim Animal Health. Emerging players are Ceva Santé Animale and Modern Veterinary Therapeutics.
Does Solvet have an API?
No public API is recorded for Solvet.
What industry is Solvet in?
Solvet's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAEAE, Antimicrobials & Anti-infectives. Its NAICS code is 325412 and its SIC code is 2834.